Day: September 6, 2023

Fourth Fund in the Suite Reinforces Commitment to Dynamic Fixed-Income Solutions MADISON, Wis., Sept. 06, 2023 (GLOBE NEWSWIRE) — Madison Investments, an independently-owned investment firm managing $22.9 billion in assets, today announces the launch of the Madison Short Term Strategic Income ETF (NYSE: MSTI), the fourth addition to its suite of actively-managed, income-driven exchange-traded funds (ETFs). This expansion follows the launch of the suite’s first fixed income fund, the Madison Aggregate Bond ETF (NYSE: MAGG), which launched last week. Each ETF in the suite utilizes a dedicated investment process designed to help investors pursue income and capital appreciation through institutional-caliber, risk-controlled investment strategies. The Madison Short Term Strategic Income ETF is designed to generate a high level of current...

LA JOLLA, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, PhD, Chief Executive Officer of GRI Bio will present at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 in New York, NY and virtually. In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website. A video webcast of the presentation will be accessible for viewing...

NEC implements WalkMe on its purchasing, procurement, and customer management systems; sees 75% reduction in support tickets across the company SAN FRANCISCO, Sept. 06, 2023 (GLOBE NEWSWIRE) — WalkMe Inc. (NASDAQ: WKME), a leading provider of digital adoption solutions, today announced that NEC Corporation has implemented WalkMe to drive the utilization of purchasing, procurement, and customer management systems as a part of its digital transformation initiatives. With WalkMe, NEC has improved business processes with a 75% reduction in employee support tickets, a 70% decrease in returned SAP Ariba submissions – all while boosting employee satisfaction and reducing support staff burden. NEC is committed to driving comprehensive digital transformation initiatives throughout the organization, customer base, and society as the core...

Promotion comes as First Watch continues its growth towards a potential for more than 2,200 restaurants in the U.S.Chief Brand Officer Matt EisenacherFirst Watch has announced the promotion of Matt Eisenacher to Chief Brand OfficerBRADENTON, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the promotion of Matt Eisenacher to Chief Brand Officer. He previously served as Senior Vice President of Brand Strategy and Innovation at First Watch, spearheading a number of initiatives aimed at growing brand awareness, defining brand positioning and implementing demand generation strategies. “Matt is a proven leader who shares our values, understands our mission and believes...

ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Heart Centre Rigshospitalet of Copenhagen University Hospital successfully treated the first patients using Stereotaxis’ Genesis Robotic Magnetic Navigation System. The Genesis system is the latest and most advanced robotic technology available for the treatment of heart rhythm disorders. Rigshospitalet is among the first in Europe, and the only hospital in Denmark, to offer the Genesis system to patients. Electrophysiologists at The Heart Centre Rigshospitalet were early pioneers, and are global leaders, in the use of advanced robot technology for the treatment of cardiac arrhythmias. Since installation of the first robotic system...

VANCOUVER, British Columbia, Sept. 06, 2023 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTCQB:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including MDMA), is pleased to announce that it has qualified for trading on the OTCQB Venture Market (the “OTCQB”) in the United States operated by the OTC Markets Group Inc. and the Company’s common shares commenced trading today on the OTCQB under the symbol “PMBHF”. PharmAla’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the ticker “MDMA”. “This listing is the result of an exceedingly long process, which I’m pleased we’ve finally completed,” stated Nick Kadysh, CEO, PharmAla Biotech. “We believe that this...